Form 4: Third Harmonic Bio Director, David P. Bonita, Acquires 20,000 Stock Options

Director David P. Bonita acquired 20,000 stock options in Third Harmonic Bio, Inc. on June 6, 2024.

Summary

• David P. Bonita, a director of Third Harmonic Bio, Inc., acquired 20,000 stock options on June 6, 2024.
• The exercise price of these options is $13.85.
• The options vest fully on the earlier of June 6, 2025, or the next annual meeting of the Issuer's stockholders, contingent on continued service.
• The options expire on June 5, 2034.
• Bonita is obligated to transfer any securities issued under these options, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. The obligation to transfer benefits to OrbiMed is a specific arrangement but doesn't inherently indicate positive or negative sentiment.

Future Outlook

The director's acquisition of stock options suggests a continued alignment of interests with the company's performance, as the options vest based on continued service.

Industry Context

Form 4 filings are routine disclosures of insider transactions, providing transparency into the actions of company directors and officers. This particular filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Related Party Transactions

• The Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.

Stakeholder Impact

• The acquisition of stock options by a director can signal confidence in the company's future performance to shareholders.
• The vesting conditions tied to continued service incentivize the director to remain engaged and contribute to the company's success.

Key Dates